News & Updates

Mood and anxiety symptoms experienced by women in the menopausal transition and in postmenopausal years may be effectively managed by nutritional interventions, according to a study.

Administering a single dose of psilocybin results in a significant reduction in depression scores over a period of 3 weeks but at the expense of increased adverse effects, according to the results of a phase II trial.

A randomized, double-blind, placebo-controlled, crossover clinical study has found that a single subcutaneous injection of bremelanotide significantly increases sexual desire for up to 24 hours through enhancing sexual brain processing in women with hypoactive sexual desire disorder (HSDD).

The use of kisspeptin appears to restore sexual and facial attraction brain processing in premenopausal women with hypoactive sexual desire disorder, without an accompanying increase in the risk of adverse effects, a study has found.

Having a pet dog or cat during early childhood is associated with a reduced risk of mental illnesses in adolescence, a retrospective cohort study in the US has shown.